Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Catalyst Biosciences Inc (CBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15037
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti-complement. Its pipeline products include factor VIIa marzeptacog alfa, for the treatment of individuals with hemophilia A and B; factor IX CB 2679d, for the treatment of hemophilia B; factor Xa variants, currently in research phase; and anti-C3: CB 2782, for treating dry age-related macular degeneration, ischemia-reperfusion injuries and inflammatory retinal diseases. The company partners with various international pharmaceutical companies to develop and commercialize its engineered human proteases. Catalyst Biosciences is headquartered in South San Francisco, California, the US.

Catalyst Biosciences Inc Key Recent Developments

Feb 08,2019: Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
Feb 06,2019: Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B
Dec 10,2018: Catalyst Biosciences to host a research & development day focused on factor VIIa and factor IX hemophilia programs
Dec 01,2018: Catalyst Biosciences Announces Updated Positive Interim Data from Its Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
Nov 01,2018: Catalyst Biosciences reports third quarter operating & financial results and provides a corporate update

This comprehensive SWOT profile of Catalyst Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Catalyst Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Catalyst Biosciences Inc – Key Information
Catalyst Biosciences Inc – Overview
Catalyst Biosciences Inc – Key Employees
Catalyst Biosciences Inc – Key Employee Biographies
Catalyst Biosciences Inc – Key Operational Heads
Catalyst Biosciences Inc – Major Products and Services
Catalyst Biosciences Inc – History
Catalyst Biosciences Inc – Company Statement
Catalyst Biosciences Inc – Locations And Subsidiaries
Catalyst Biosciences Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Catalyst Biosciences Inc – Business Description
Catalyst Biosciences Inc – Corporate Strategy
Catalyst Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Catalyst Biosciences Inc – Strengths
Catalyst Biosciences Inc – Weaknesses
Catalyst Biosciences Inc – Opportunities
Catalyst Biosciences Inc – Threats
Catalyst Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Catalyst Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Catalyst Biosciences Inc, Key Information
Catalyst Biosciences Inc, Key Ratios
Catalyst Biosciences Inc, Share Data
Catalyst Biosciences Inc, Major Products and Services
Catalyst Biosciences Inc, History
Catalyst Biosciences Inc, Key Employees
Catalyst Biosciences Inc, Key Employee Biographies
Catalyst Biosciences Inc, Key Operational Heads
Catalyst Biosciences Inc, Other Locations
Catalyst Biosciences Inc, Subsidiaries
Catalyst Biosciences Inc, Key Manufacturing facilities
Catalyst Biosciences Inc, Key Competitors
Catalyst Biosciences Inc, SWOT Analysis
Catalyst Biosciences Inc, Ratios based on current share price
Catalyst Biosciences Inc, Annual Ratios
Catalyst Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Catalyst Biosciences Inc, Performance Chart
Catalyst Biosciences Inc, Ratio Charts

★海外企業調査レポート[Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • P2P Global Investments PLC (P2P):企業の財務・戦略的SWOT分析
    P2P Global Investments PLC (P2P) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kot Addu Power Co Ltd (KAPCO):企業の財務・戦略的SWOT分析
    Kot Addu Power Co Ltd (KAPCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • Lytron Inc.:企業の戦略・SWOT・財務情報
    Lytron Inc. - Strategy, SWOT and Corporate Finance Report Summary Lytron Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Senvion SA:企業の戦略的SWOT分析
    Senvion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Sanofi Genzyme:企業の戦略・SWOT・財務分析
    Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report Summary Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務情報
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • SIG Combibloc Group Ltd.:企業の戦略・SWOT・財務情報
    SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cosmo Pharmaceuticals NV (COPN)-医療機器分野:企業M&A・提携分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatm …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • American Equity Investment Life Holding Company:企業の戦略・SWOT・財務情報
    American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report Summary American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Timberland LLC:戦略・SWOT・企業財務分析
    Timberland LLC - Strategy, SWOT and Corporate Finance Report Summary Timberland LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Recipharm AB (RECI B):企業の財務・戦略的SWOT分析
    Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆